Defensins in STI-Mediated Enhanced HIV Infectivity
防御素在性传播感染介导的艾滋病毒感染性增强中的作用
基本信息
- 批准号:7927752
- 负责人:
- 金额:$ 20.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-03-01 至 2010-07-27
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAccountingAcuteAntibodiesBacterial VaginosisCD4 Positive T LymphocytesChargeClinicalClinical ResearchComplexConditioned Culture MediaDefensinsDevelopmentEndocervixEpidemiologyEpithelial CellsFemaleGene Expression RegulationGenital systemGlycoproteinsGoalsHDAC5 geneHDAC6 geneHIVHIV Envelope Protein gp120HIV InfectionsHIV-1HeparinHumanIn VitroIndividualInfectionInflammatory ResponseIntestinesLeadLigandsLiquid substanceLongitudinal StudiesMediatingMolecularMucosal ImmunityMucous MembraneNeisseria gonorrhoeaePaneth CellsPredispositionPrevention strategyPrincipal InvestigatorProbabilityProteinsPublicationsRegulationReportingResearchRoleRouteSexual TransmissionSexually Transmitted DiseasesSiteSpecimenStructureT-Cell DepletionVaccinesVaginaVirusWomananalogantimicrobial peptideclinically significantcytokinedomain mappinginsightmicrobicidemutantnovelprogramspublic health relevanceresponsetranscytosistransmission process
项目摘要
DESCRIPTION (provided by applicant): Sexual transmission is the most common route of HIV infection and women account for nearly half of those infected worldwide. Prevention strategies employing different approaches are needed to reduce the probability of transmission. Epidemiologic and clinical studies strongly indicate that sexually transmitted infections (STIs) increase the likelihood of HIV transmission. Although the contribution of STIs to the increase in HIV transmission is likely to be multifaceted (38, 84), understanding how STIs enhance HIV infection is vital to the development of new strategies for the prevention of HIV. Defensins are antimicrobial peptides important to innate mucosal immunity. Indeed, the levels of defensins in genital fluid are frequently elevated in individuals with STIs, suggesting a potential role in modulating HIV transmission. Human defensins 5 and 6 (HD5 and HD6) are the most abundant antimicrobial peptides in the intestine, a major site of CD4+ T cell depletion during acute HIV infection. HD5 and HD6 are constitutively expressed in Paneth cells, but also found in the female genital mucosa. Induction of HD5 has been reported in genital fluid from individuals with C. trachomatis (CT) and N. gonorrhoeae (GC) infection, and bacterial vaginosis (BV). Our recent publication indicates that HD5 and HD6 significantly enhance HIV infectivity and that induction of these defensins contributes to enhanced HIV infection of conditioned media from N. gonorrhoeae-exposed vaginal epithelial cells. The HIV enhancing effect of HD5 and HD6 is more pronounced with R5 virus compared to X4 virus, suggesting its clinical significance as R5 viruses are almost exclusively detected upon sexual transmission. Importantly, we obtained and analyzed endocervical specimens from women with or without CT infection and found that HD5 proteins were elevated in clinical specimens from CT-infected women. Additionally, elevated levels of HD5 in endocervical specimens from women with STIs were associated with enhanced in vitro HIV infectivity. We hypothesize that STIs may contribute to increased HIV transmission by up-regulating innate effectors such as defensins that in turn promote HIV infectivity and induce inflammatory responses in the genital mucosa. The consequence of elevated levels of defensins in response to STIs may not only lead to increased susceptibility to HIV infection but also negatively impact the efficacy of microbicides and antibody-inducing vaccines. The goal of this proposal is to establish the role of defensins in STI-mediated enhanced HIV infectivity and dissect its underlying molecular mechanism. This study will provide a better understanding of the complex function of defensins in mucosal transmission of HIV, and offer insight into the development of novel prevention strategies, especially in the setting of STIs.
PUBLIC HEALTH RELEVANCE: The goal of this project is aim to understand the role of defensins in sexual transmitted infection (STI)-mediated enhancement of HIV infectivity.
描述(由申请人提供):性传播是艾滋病毒感染的最常见途径,妇女占全球感染者的近一半。需要采取不同的预防策略来降低传播的可能性。流行病学和临床研究强烈表明,性传播感染增加了艾滋病毒传播的可能性。虽然性传播感染对艾滋病毒传播的增加可能是多方面的(38,84),但了解性传播感染如何增加艾滋病毒感染对制定预防艾滋病毒的新战略至关重要。防御素是一种对先天性粘膜免疫有重要作用的抗菌肽。事实上,生殖器液中的防御素水平在性传播感染患者中经常升高,这表明在调节艾滋病毒传播方面具有潜在作用。人防御素5和6(HD5和HD6)是肠道中最丰富的抗微生物肽,肠道是急性HIV感染期间CD4+ T细胞耗竭的主要部位。HD5和HD6在潘氏细胞中组成型表达,但也在女性生殖器粘膜中发现。据报道,在患有C的个体的生殖液中诱导HD5。沙眼衣原体(CT)和N.淋病(GC)感染和细菌性阴道病(BV)。我们最近发表的文章表明,HD5和HD6显著增强HIV感染性,这些防御素的诱导有助于增强来自N.淋病暴露的阴道上皮细胞。与X4病毒相比,HD5和HD6对R5病毒的HIV增强作用更明显,这表明其临床意义,因为R5病毒几乎仅在性传播时检测到。重要的是,我们获得并分析了有或没有CT感染的妇女的宫颈标本,发现CT感染妇女的临床标本中HD5蛋白升高。此外,性病妇女宫颈标本中HD5水平升高与体外HIV感染性增强有关。我们推测,性传播感染可能有助于增加艾滋病毒的传播,通过上调先天效应,如防御素,反过来促进艾滋病毒的感染性和诱导生殖器粘膜的炎症反应。性传播感染后防御素水平升高的结果不仅可能导致对HIV感染的易感性增加,而且还对杀微生物剂和抗体诱导疫苗的效力产生负面影响。本研究的目的是建立防御素在STI介导的增强HIV感染性中的作用,并剖析其潜在的分子机制。这项研究将提供一个更好的理解的复杂功能的防御素在粘膜传播的艾滋病毒,并提供深入了解新的预防策略的发展,特别是在设置性传播感染。
公共卫生关系:本项目的目的是了解防御素在性传播感染(STI)介导的HIV感染性增强中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Theresa L Chang其他文献
Theresa L Chang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Theresa L Chang', 18)}}的其他基金
Sex difference in intestinal immune dysfunction, SHIV infection and reservoir
肠道免疫功能障碍、SHIV感染和储存者的性别差异
- 批准号:
10654740 - 财政年份:2021
- 资助金额:
$ 20.79万 - 项目类别:
Sex difference in intestinal immune dysfunction, SHIV infection and reservoir
肠道免疫功能障碍、SHIV感染和储存者的性别差异
- 批准号:
10462764 - 财政年份:2021
- 资助金额:
$ 20.79万 - 项目类别:
Impact of gender affirming hormone therapy on immune modulation and HIV infection in transgender young adults
性别肯定激素治疗对跨性别年轻人免疫调节和艾滋病毒感染的影响
- 批准号:
10364706 - 财政年份:2021
- 资助金额:
$ 20.79万 - 项目类别:
Sex difference in intestinal immune dysfunction, SHIV infection and reservoir
肠道免疫功能障碍、SHIV感染和储存者的性别差异
- 批准号:
10327456 - 财政年份:2021
- 资助金额:
$ 20.79万 - 项目类别:
Impact of gender affirming hormone therapy on immune modulation and HIV infection in transgender young adults
性别肯定激素治疗对跨性别年轻人免疫调节和艾滋病毒感染的影响
- 批准号:
10257722 - 财政年份:2021
- 资助金额:
$ 20.79万 - 项目类别:
Role of IFNe in immune modulation and HIV infection
IFNe在免疫调节和HIV感染中的作用
- 批准号:
10356898 - 财政年份:2018
- 资助金额:
$ 20.79万 - 项目类别:
Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera
Depo-Provera 对先天免疫、微生物组和 HIV 传播的调节
- 批准号:
9045100 - 财政年份:2013
- 资助金额:
$ 20.79万 - 项目类别:
Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera
Depo-Provera 对先天免疫、微生物组和 HIV 传播的调节
- 批准号:
8716673 - 财政年份:2013
- 资助金额:
$ 20.79万 - 项目类别:
Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera
Depo-Provera 对先天免疫、微生物组和 HIV 传播的调节
- 批准号:
8885647 - 财政年份:2013
- 资助金额:
$ 20.79万 - 项目类别:
Modulation of innate immunity,microbiome and HIV transmission by Depo-Provera
Depo-Provera 对先天免疫、微生物组和 HIV 传播的调节
- 批准号:
8593906 - 财政年份:2013
- 资助金额:
$ 20.79万 - 项目类别:
相似海外基金
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 20.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 20.79万 - 项目类别:
Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
- 批准号:
24K04974 - 财政年份:2024
- 资助金额:
$ 20.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
- 批准号:
23K01686 - 财政年份:2023
- 资助金额:
$ 20.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
- 批准号:
23K01692 - 财政年份:2023
- 资助金额:
$ 20.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
- 批准号:
23K01695 - 财政年份:2023
- 资助金额:
$ 20.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
- 批准号:
23K01713 - 财政年份:2023
- 资助金额:
$ 20.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
- 批准号:
2312319 - 财政年份:2023
- 资助金额:
$ 20.79万 - 项目类别:
Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
- 批准号:
23K01715 - 财政年份:2023
- 资助金额:
$ 20.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 20.79万 - 项目类别: